Actor
Axalbion SA
Clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with limited treatment options
Specialties
Primary Therapeutic Areas
0. COVID-19
1.0 Therapeutic & Diagnostic
1.00 Antibodies & Anti-infectious
1.10 Small Molecules
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
COVID-Areas, Immunology & Allergy, Infectious Diseases, Ophtalomology
Main sector
Biotech
Contact
EPFL Innovation Park Building C, Chemin de la Dent-d'Oche 1A
1015 Lausanne / VD
+41 79 715 37 25